Clinical trial
Diagnostic and Prognostic Value of Liquid Biopsy in Germ Cell Tumors
NCT07376096 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Diagnostic and Prognostic Value of Liquid Biopsy in Germ Cell Tumors
- Lead sponsor
- Medical University of Graz
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- February 16, 2026
- Completion date
- February 15, 2030
- Enrollment
- 200 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
100 metastatic patients, 100 stage i patients